KarXT (Karuna Therapeutics) met its primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia, the company has announced. KarXT is an oral coformulation of ...

Jørgen G Bramness; Øystein H Gundersen; Joar Guterstam; Eline B Rognli; Maija Konstenius; Else-Marie Løberg; Sigrid Medhus; Lars Tanum; Johan Franck In this context, we hypothesize that the ...

The investigational combination xanomeline-trospium (KarXT) was effective and well tolerated in individuals with schizophrenia who were experiencing acute psychosis, according to the randomized ...

Meg and Scott knew something was going on with their son Kyle when, during the pandemic, he began refusing to get out of bed to attend class online. Up until then, Kyle had been like a dream son: tall ...

CNN — A British psychiatrist has warned of the mental health impact of political events after a man suffered acute psychotic illness triggered by Brexit. The unidentified middle-aged man was brought ...

AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid ...

As a psychiatrist and addiction medicine physician, I am surprised that some patients and their families still believe marijuana is a benign and innocuous substance. Over the past several years, I ...

A teenage boy who was initially hospitalized for a mild case of COVID-19 developed severe psychosis just days later. The unnamed 16-year-old, who was not vaccinated, was admitted to a hospital in the ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Defendant Thomas Kinworthy Jr. looks at his attorneys during the first day of his first-degree murder trial on Monday, April, 22, ...

AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid ...